Divi's Laboratories Ltd Share Price

Overview

Divi's Laboratories Ltd share price is currently ₹8,487.84, up by ₹89.11 (1.06%) from its previous closing price of ₹8,398.73. The share price has gained 16.53% over the past month and gained 44.85% over the past year. The stock's 52-week low and high are ₹5,528.30 and ₹8,605.29, respectively. Divi's Laboratories Ltd has a market capitalisation of ₹ 2,30,000.00 Cr. The share price was last updated on 20 Aug 2026, 03:51 PM IST.

Divi's Laboratories Ltd
Divi's Laboratories Ltd
DIVISLAB
 0.00
 89.11
1.06%
Healthcare
 0.00(%)1D

Updated: 20 Aug 2026, 03:51:47 pm IST

Market Data

Open Price

 8,508.37

Prev. Close

 8,398.73
 8,449.59

Day Low

 8,515.87

Day High

 5,528.30

52 Week Low

 8,605.29

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

76.90

Sector PE

42.16

PB Ratio

13.42

Sector PB

5.82

EPS

110.38

Dividend Yield

0.50

Today's Volume

197.813 K

5 Day Avg. Volume

274.091 K

PEG Ratio

4.47

Market Cap.

₹ 2,30,000.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 1500% at ₹30/Share
24-Jul-202624-Jul-2026
DividendsFinal Dividend of 1500% at ₹30/Share
25-Jul-202525-Jul-2025

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
SBI Equity Hybrid Fund - Regular Plan - IDCW23.00 Lac
23.00 Lac
no change
SBI Large Cap Fund - Regular Plan - Growth20.32 Lac
20.32 Lac
no change
HDFC Flexi Cap Fund - Growth18.01 Lac
18.94 Lac
(5.15%)
SBI Focused Fund - Regular Plan - Growth15.70 Lac
15.70 Lac
no change
Axis ELSS Tax Saver Fund - Regular Plan - Growth10.03 Lac
9.36 Lac
(6.63%)

About Divi's Laboratories Ltd 👋

Divi's Laboratories Limited is an India-based company, which is engaged in pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company's products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Quetiapine Fumarate, Naproxen Sodium, Olmesartan, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl, and others. In addition to generics, the Company, through its custom synthesis, supports innovator pharma companies. It is engaged in custom synthesis (contract manufacturing services) of APIs and Intermediates for global innovator companies with a portfolio of products across diverse therapeutic areas. The Company's subsidiaries include Divis Laboratories (USA) Inc. and Divi's Laboratories Europe AG.

News & Events

Frequently Asked Questions

What is the share price of Divi's Laboratories Ltd?

What is the market cap of Divi's Laboratories Ltd?

Should I buy Divi's Laboratories Ltd stock now?

What is the 52 week high and low of Divi's Laboratories Ltd?

Is the Divi's Laboratories Ltd stock good to buy?

Is Divi's Laboratories Ltd a good buy for the long term?

Is Divi's Laboratories Ltd overvalued or undervalued?

What is the PE and PB ratio of Divi's Laboratories Ltd?

Start Now